PEPFAR's annual planning process is done either at the country (COP) or regional level (ROP).
PEPFAR's programs are implemented through implementing partners who apply for funding based on PEPFAR's published Requests for Applications.
Since 2010, PEPFAR COPs have grouped implementing partners according to an organizational type. We have retroactively applied these classifications to earlier years in the database as well.
Also called "Strategic Areas", these are general areas of HIV programming. Each program area has several corresponding budget codes.
Specific areas of HIV programming. Budget Codes are the lowest level of spending data available.
Expenditure Program Areas track general areas of PEPFAR expenditure.
Expenditure Sub-Program Areas track more specific PEPFAR expenditures.
Object classes provide highly specific ways that implementing partners are spending PEPFAR funds on programming.
Cross-cutting attributions are areas of PEPFAR programming that contribute across several program areas. They contain limited indicative information related to aspects such as human resources, health infrastructure, or key populations programming. However, they represent only a small proportion of the total funds that PEPFAR allocates through the COP process. Additionally, they have changed significantly over the years. As such, analysis and interpretation of these data should be approached carefully. Learn more
Beneficiary Expenditure data identify how PEPFAR programming is targeted at reaching different populations.
Sub-Beneficiary Expenditure data highlight more specific populations targeted for HIV prevention and treatment interventions.
PEPFAR sets targets using the Monitoring, Evaluation, and Reporting (MER) System - documentation for which can be found on PEPFAR's website at https://www.pepfar.gov/reports/guidance/. As with most data on this website, the targets here have been extracted from the COP documents. Targets are for the fiscal year following each COP year, such that selecting 2016 will access targets for FY2017. This feature is currently experimental and should be used for exploratory purposes only at present.
Years of mechanism: 2007 2008 2009
ACTIVITY DESCRIPTION: ASM has the capacity to support the PEPFAR program by ensuring that laboratories possess the necessary organizational and technical infrastructure to provide quality laboratory testing and results in support of HIV prevention, care, and treatment programs, especially for tuberculosis (TB) and opportunistic infections (OI). ASM can provide technical assistance through carefully chosen experts from among ASM's more than 5,000 clinical laboratory microbiologists and immunologists worldwide.
For COP07, ASM will focus on improving the quality and capacity of TB and OI diagnosis in Nigeria. The following four activities will support this goal: development of a comprehensive quality assurance (QA) and quality control (QC) system for TB, review and improvements to the TB training curriculum (and SOP's) currently used in Nigeria, provision of technical expertise on the structural design of new and existing laboratories involved in diagnosis of TB (specifically. culture and drug resistance testing) and improvement of training for simple OI diagnosis (microscopy). ASM will work closely with USG-Nigeria to ensure that these activities are coordinated with the (Government of Nigeria) GON and those organizations already supporting TB diagnosis and treatment in Nigeria (including, UMD-ACTION, Harvard-APIN, German Leprosy Group, GHAIN, Netherlands Leprosy Group and WHO). ASM will work through the in-country Laboratory Working group established by USG-Nigeria to ensure that activities and deliverables are developed and implemented in a harmonized fashion.
CONTRIBUTIONS TO OVERALL PROGRAM AREA ASM will contribute nationally to TB and OI diagnostic programs through development of a QA program, improvements to laboratory training programs and improved lab infrastructure at NTLCP centres
LINKS TO OTHER ACTIVITIES Improved TB and OI diagnosis programs directed at HIV infected individuals, results in a stronger palliative care program (HBHC-3.3.06 and HVTB-3.3.07).
POPULATIONS BEING TARGETED ASM will develop/improve training programs provided to laboratorians working in clinical health care facilities for improved disgnosis of TB and OI. ASM will also improve the infrastructrure of laboratories where these individuals currently work.
KEY LEGISLATIVE ISSUES ADDRESSED N/A
EMPHASIS AREAS The major emphasis of this activity is quality assurance and quality improvement of laboratory testing.
